• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人血清促红细胞生成素的分子电荷异质性

Molecular charge heterogeneity of human serum erythropoietin.

作者信息

Wide L, Bengtsson C

机构信息

Department of Clinical Chemistry, University Hospital, Uppsala, Sweden.

出版信息

Br J Haematol. 1990 Sep;76(1):121-7. doi: 10.1111/j.1365-2141.1990.tb07846.x.

DOI:10.1111/j.1365-2141.1990.tb07846.x
PMID:2223631
Abstract

The charge heterogeneity of human serum erythropoietin (S-Epo) was studied in 89 serum specimens from 78 subjects by zone electrophoresis in 0.17% agarose suspension at pH 8.6. The electrophoretic elution profiles of S-Epo were determined with a radioimmunoassay for Epo. The number of Epo peaks indicated that at least 20-30 different forms of Epo were present in a single serum specimen. The median charge of Epo, estimated as its median electrophoretic mobility, was determined for each serum specimen. This median charge was measured in 10 healthy adults, 46 patients with anaemia, six patients with secondary polycythaemia, one patient with polycythaemia vera treated by phlebotomy, and six healthy newborn infants (cord sera). Forty-four of the patients with anaemia had a median charge of S-Epo within the reference range for healthy adults, while all the patients with polycythaemia and the newborn infants had less negatively charged forms of S-Epo. In nine patients in whom the S-Epo level had a circadian rhythm, the forms of S-Epo in the evening were less negative than those in the morning. The median charge of recombinant preparations was much less negative than that of S-Epo in healthy individuals, while that of the 2nd International Reference Preparation was more negative than in any of the 78 subjects analysed. A significant change to less negatively charged S-Epo forms was observed 24 h after a subcutaneous injection of recombinant Epo in one patient, who before the injection had a normal median charge and concentration of S-Epo. In conclusion, Epo exhibits a considerable charge heterogeneity in individual serum specimens, the forms of S-Epo in the morning may differ from those in the evening, those in adults differ from those in newborn infants, and those in patients with anaemia differ from those in polycythaemia. The results also suggest that the methods used in this study may be useful for detecting the presence of injected recombinant Epo in the blood in persons with a normal endogenous Epo production.

摘要

采用pH 8.6的0.17%琼脂糖悬浮液区带电泳法,对78名受试者的89份血清标本中的人血清促红细胞生成素(S-Epo)电荷异质性进行了研究。用促红细胞生成素放射免疫分析法测定S-Epo的电泳洗脱图谱。促红细胞生成素峰的数量表明,单个血清标本中至少存在20 - 30种不同形式的促红细胞生成素。针对每个血清标本,测定以促红细胞生成素中位电泳迁移率估算的促红细胞生成素中位电荷。对10名健康成年人、46名贫血患者、6名继发性红细胞增多症患者、1名接受放血治疗的真性红细胞增多症患者以及6名健康新生儿(脐血血清)测量了该中位电荷。44名贫血患者的S-Epo中位电荷在健康成年人的参考范围内,而所有红细胞增多症患者和新生儿的S-Epo带负电形式较少。在9名S-Epo水平具有昼夜节律的患者中,晚上的S-Epo形式比早上的带负电程度更低。重组制剂的中位电荷比健康个体的S-Epo带负电程度低得多,而第二国际参考制剂的中位电荷比所分析的78名受试者中的任何一人都更带负电。在一名皮下注射重组促红细胞生成素24小时后的患者中观察到,其S-Epo形式明显转变为带负电程度更低的形式,该患者注射前S-Epo的中位电荷和浓度正常。总之,促红细胞生成素在个体血清标本中表现出相当大的电荷异质性,早上的S-Epo形式可能与晚上不同,成年人的与新生儿的不同,贫血患者的与红细胞增多症患者的不同。结果还表明,本研究中使用的方法可能有助于检测内源性促红细胞生成素产生正常的人群血液中注射的重组促红细胞生成素的存在。

相似文献

1
Molecular charge heterogeneity of human serum erythropoietin.人血清促红细胞生成素的分子电荷异质性
Br J Haematol. 1990 Sep;76(1):121-7. doi: 10.1111/j.1365-2141.1990.tb07846.x.
2
Serum erythropoietin in the diagnosis of polycythaemia and after phlebotomy treatment.血清促红细胞生成素在真性红细胞增多症诊断及放血治疗后的应用
Br J Haematol. 1992 Aug;81(4):603-6. doi: 10.1111/j.1365-2141.1992.tb02999.x.
3
Serum erythropoietin concentrations measured by radioimmunoassay in normal, polycythemic, and anemic dogs and cats.
J Vet Intern Med. 1994 Jan-Feb;8(1):18-25. doi: 10.1111/j.1939-1676.1994.tb03191.x.
4
[Erythropoietin determination in clinical medicine].
Rinsho Byori. 1993 Apr;41(4):361-5.
5
Circadian rhythm of erythropoietin in human serum.人血清中促红细胞生成素的昼夜节律。
Br J Haematol. 1989 May;72(1):85-90. doi: 10.1111/j.1365-2141.1989.tb07657.x.
6
Assessment of an EIA for measuring human serum erythropoietin as compared with RIA and an in-vitro bioassay.
Br J Haematol. 1992 Apr;80(4):431-6. doi: 10.1111/j.1365-2141.1992.tb04554.x.
7
[Serum erythropoietin levels: a new diagnostic tool?].[血清促红细胞生成素水平:一种新的诊断工具?]
Schweiz Rundsch Med Prax. 1989 May 9;78(19):551-6.
8
Detection in blood and urine of recombinant erythropoietin administered to healthy men.
Med Sci Sports Exerc. 1995 Nov;27(11):1569-76.
9
[Clinical usefulness of measurement of erythropoietin in blood].[血液中促红细胞生成素测定的临床应用价值]
Rinsho Ketsueki. 1993 Aug;34(8):895-903.
10
Plasma erythropoietin by high-detectability immunoradiometric assay in untreated and treated patients with polycythaemia vera and essential thrombocythaemia.采用高灵敏度免疫放射分析法定量检测未经治疗及经治疗的真性红细胞增多症和原发性血小板增多症患者的血浆促红细胞生成素。
Eur J Haematol. 1998 May;60(5):278-82. doi: 10.1111/j.1600-0609.1998.tb01040.x.

引用本文的文献

1
A Reference Standard for Analytical Testing of Erythropoietin.促红细胞生成素分析检测的参比标准。
Pharm Res. 2022 Mar;39(3):553-562. doi: 10.1007/s11095-022-03213-1. Epub 2022 Mar 15.
2
Recombinant erythropoietin in humans has a prolonged effect on circulating erythropoietin isoform distribution.重组促红细胞生成素对人体循环促红细胞生成素异构体分布具有持久影响。
PLoS One. 2014 Oct 21;9(10):e110903. doi: 10.1371/journal.pone.0110903. eCollection 2014.
3
Kidney-synthesized erythropoietin is the main source for the hypoxia-induced increase in plasma erythropoietin in adult humans.
肾脏合成的促红细胞生成素是成人缺氧诱导血浆促红细胞生成素增加的主要来源。
Eur J Appl Physiol. 2014 Jun;114(6):1107-11. doi: 10.1007/s00421-014-2844-7. Epub 2014 Feb 15.
4
The role and regulation of erythropoietin (EPO) and its receptor in skeletal muscle: how much do we really know?促红细胞生成素(EPO)及其受体在骨骼肌中的作用和调节:我们究竟了解多少?
Front Physiol. 2013 Jul 15;4:176. doi: 10.3389/fphys.2013.00176. eCollection 2013.
5
The evolving science of detection of 'blood doping'.不断发展的“血液兴奋剂”检测科学。
Br J Pharmacol. 2012 Mar;165(5):1306-15. doi: 10.1111/j.1476-5381.2011.01822.x.
6
Effect of intermittent hypoxia on hematological parameters after recombinant human erythropoietin administration.重组人促红细胞生成素给药后间歇性低氧对血液学参数的影响。
Eur J Appl Physiol. 2009 Nov;107(4):429-36. doi: 10.1007/s00421-009-1141-3. Epub 2009 Aug 8.
7
Erythropoietin and blood doping.促红细胞生成素与血液兴奋剂。
Br J Sports Med. 2006 Jul;40 Suppl 1(Suppl 1):i30-4. doi: 10.1136/bjsm.2006.027532.
8
Dynamic control of oligosaccharide modification in the mammary gland: linking recombinant human erythropoietin functional analysis of transgenic mouse milk-derived hEPO.乳腺中寡糖修饰的动态控制:转基因小鼠乳汁来源的人促红细胞生成素(hEPO)的重组人促红细胞生成素功能分析
Transgenic Res. 2006 Feb;15(1):37-55. doi: 10.1007/s11248-005-3519-2.
9
The future of doping control in athletes. Issues related to blood sampling.运动员兴奋剂检查的未来。与血液采样相关的问题。
Sports Med. 1999 Jul;28(1):25-33. doi: 10.2165/00007256-199928010-00003.
10
Women's greatest handicaps: sex, medicine, and men.女性最大的障碍:性别、医学与男性。
Br J Sports Med. 1999 Apr;33(2):76-7.